Pharmaceutical industry, innovation and challenges for public health

Case studies from Malaysia and Pakistan

Zaheer Ud Din Babar, Mohamed Izham Mohamed Ibrahim, Mohamed Azmi Ahmad Hassali

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

This study analyses the effect of pro-industrial pharmaceutical policies by the governments of Malaysia and Pakistan and their affect on public health. The study concludes that the pharmaceutical industry is not 'novel' and the desire to turn it into an important economic player is not being achieved. Governmental support given to the pharmaceutical industry is not a guarantee for access to and use of medicines as the issues such as promotion of branded drugs, self-sufficiency and high medicine prices still remain. New approaches are required to understand the competing interest between industrial policy and drug policy by including consumers and social scientist in this debate.

Original languageEnglish
Pages (from-to)193-204
Number of pages12
JournalJournal of Pharmaceutical Health Services Research
Volume2
Issue number4
Early online date26 Jul 2011
DOIs
Publication statusPublished - 1 Dec 2011
Externally publishedYes

Fingerprint

Malaysia
Pakistan
Drug Industry
Public Health
Drug and Narcotic Control
Prodrugs
Pharmaceutical Preparations
Economics
Medicine
Pharmaceutical industry
Public health
Innovation
Self-sufficiency
Drugs
Pharmaceuticals
Government
Guarantee
Industrial policy
Drug policy

Cite this

@article{f474c3e7ca6f4dc09b05f13be399ad68,
title = "Pharmaceutical industry, innovation and challenges for public health: Case studies from Malaysia and Pakistan",
abstract = "This study analyses the effect of pro-industrial pharmaceutical policies by the governments of Malaysia and Pakistan and their affect on public health. The study concludes that the pharmaceutical industry is not 'novel' and the desire to turn it into an important economic player is not being achieved. Governmental support given to the pharmaceutical industry is not a guarantee for access to and use of medicines as the issues such as promotion of branded drugs, self-sufficiency and high medicine prices still remain. New approaches are required to understand the competing interest between industrial policy and drug policy by including consumers and social scientist in this debate.",
keywords = "Innovation, Malaysia, Pakistan, Pharmaceutical industry, Public health",
author = "Babar, {Zaheer Ud Din} and Ibrahim, {Mohamed Izham Mohamed} and Hassali, {Mohamed Azmi Ahmad}",
year = "2011",
month = "12",
day = "1",
doi = "10.1111/j.1759-8893.2011.00058.x",
language = "English",
volume = "2",
pages = "193--204",
journal = "Journal of Pharmaceutical Health Services Research",
issn = "1759-8885",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

Pharmaceutical industry, innovation and challenges for public health : Case studies from Malaysia and Pakistan. / Babar, Zaheer Ud Din; Ibrahim, Mohamed Izham Mohamed; Hassali, Mohamed Azmi Ahmad.

In: Journal of Pharmaceutical Health Services Research, Vol. 2, No. 4, 01.12.2011, p. 193-204.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Pharmaceutical industry, innovation and challenges for public health

T2 - Case studies from Malaysia and Pakistan

AU - Babar, Zaheer Ud Din

AU - Ibrahim, Mohamed Izham Mohamed

AU - Hassali, Mohamed Azmi Ahmad

PY - 2011/12/1

Y1 - 2011/12/1

N2 - This study analyses the effect of pro-industrial pharmaceutical policies by the governments of Malaysia and Pakistan and their affect on public health. The study concludes that the pharmaceutical industry is not 'novel' and the desire to turn it into an important economic player is not being achieved. Governmental support given to the pharmaceutical industry is not a guarantee for access to and use of medicines as the issues such as promotion of branded drugs, self-sufficiency and high medicine prices still remain. New approaches are required to understand the competing interest between industrial policy and drug policy by including consumers and social scientist in this debate.

AB - This study analyses the effect of pro-industrial pharmaceutical policies by the governments of Malaysia and Pakistan and their affect on public health. The study concludes that the pharmaceutical industry is not 'novel' and the desire to turn it into an important economic player is not being achieved. Governmental support given to the pharmaceutical industry is not a guarantee for access to and use of medicines as the issues such as promotion of branded drugs, self-sufficiency and high medicine prices still remain. New approaches are required to understand the competing interest between industrial policy and drug policy by including consumers and social scientist in this debate.

KW - Innovation

KW - Malaysia

KW - Pakistan

KW - Pharmaceutical industry

KW - Public health

UR - http://www.scopus.com/inward/record.url?scp=84859812546&partnerID=8YFLogxK

U2 - 10.1111/j.1759-8893.2011.00058.x

DO - 10.1111/j.1759-8893.2011.00058.x

M3 - Review article

VL - 2

SP - 193

EP - 204

JO - Journal of Pharmaceutical Health Services Research

JF - Journal of Pharmaceutical Health Services Research

SN - 1759-8885

IS - 4

ER -